LPCN · Lipocine Inc.
Market Cap
$17.31M
Shares
8.24M
Volume · Oct 5
13.01K
Avg daily vol (3M)
36.49K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.05
Open$2.08
Day$2.05–2.13
52W close$1.94–11.26
Avg vol 30d35K
Short int99K · 1.2% float · 4.6d
Short vol15%
DataJan 2020–Oct 2026
Filing10-Q · Aug 4
Up next
filed Aug 4, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$1.57M
Trailing 12 months
Net income (TTM)
−$11.85M
Trailing 12 months
Revenue growth YoY
-69.5%
Year over year
Operating margin
-800.8%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+53.5%
Year over year · more shares
Price change (1Y)
-33.7%
Trailing year
Short interest
1.2%
Latest settlement · 4.6 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 15.3 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−53%
below
Price vs 50-day avg
−5%
below
RSI (14)
40
neutral
MACD trend
Negative
52-week position
1%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−15%
trailing
6-month return
−14%
trailing
YTD return
−74%
this year
Relative strength
−26%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $4 — 200d above 50d
Institutional flow
Distributing
-23% holders QoQ · +4 funds added
Insider flow
Accumulating
Net +$82.2K over 90 days · 0% sells
Short interest
Falling
1.21% of float · ▼ -1.5% MoM · 4.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
36 holders — mid 3-yr range
Squeeze score
43
elevated · 0–100
Fundamentals
Revenue growth
−82%
Y/Y
EPS growth
+46%
Y/Y
Free cash flow
$-9.9M
Balance sheet
$1.3M
net cash
Quant / Vol
risk profile
Volatility
109%
annualized · 1-yr
Max drawdown
−83%
past year
ATR
5.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−53%
Bearish
Price vs 50-day avg
−5%
Bearish
RSI (14)
40
Neutral
MACD trend
Negative
Bearish
52-week position
1%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $2 › 200d $4 — 200d above 50d
Institutional flow
Distributing
-23% holders QoQ · +4 funds added
Insider flow
Accumulating
Net +$82.2K over 90 days · 0% sells
Short interest
Falling
1.21% of float · ▼ -1.5% MoM · 4.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
36 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $2
Now $2 · 1%
Range high $11
vs 200-day avg -53%
vs 50-day avg -5%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
LPCN
this stock
Lipocine Inc.
|
$17.31M | -74.5% | -82.3% | — | 1.2% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$133.37B | +11.3% | +46.2% | 30.7 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$81.13B | -4.8% | +20.8% | 19.5 | 2.5% |
|
MRNA
Moderna, Inc.
|
$79.40B | +544.3% | +4.3% | — | 8.2% |
|
CSLLY
Csl Ltd
|
$61.25B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| LPCN | -2.4% | -15.3% | -13.9% | -6.8% | -74.5% |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | -2.2% | -14.8% | -26.1% | -7.7% | -87.3% |